Safety and Immunogenicity of a New Mammalian Cell-Derived Recombinant Hepatitis B Vaccine Containing Pre-S1 and Pre-S2 Antigens in Adults
Israel Medical Association Journal
June 1997
Safety and Immunogenicity of a New Mammalian Cell-Derived Recombinant Hepatitis B Vaccine Containing Pre-S1 and Pre-S2 Antigens in Adults
June 1, 1997 |